Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 6.25 GBX -0.79% Market Closed
Market Cap: 297.9m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Balance Sheet

Balance Sheet Decomposition
Allergy Therapeutics PLC

Current Assets 35.3m
Cash & Short-Term Investments 13.5m
Receivables 9.9m
Other Current Assets 11.9m
Non-Current Assets 33.7m
Long-Term Investments 5.3m
PP&E 23.4m
Intangibles 5m
Current Liabilities 25.3m
Accounts Payable 20.1m
Other Current Liabilities 5.2m
Non-Current Liabilities 17.3m
Long-Term Debt 8.1m
Other Non-Current Liabilities 9.2m

Balance Sheet
Allergy Therapeutics PLC

Rotate your device to view
Balance Sheet
Currency: GBP
Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023
Assets
Cash & Cash Equivalents
2
21
23
22
16
27
37
40
21
15
Cash
2
21
23
22
16
27
37
40
21
15
Total Receivables
4
4
6
6
5
8
6
5
6
5
Accounts Receivables
3
3
5
4
4
4
4
3
3
2
Other Receivables
1
1
1
2
2
4
2
2
3
3
Inventory
6
7
8
7
9
9
10
11
11
12
Other Current Assets
1
2
1
2
1
1
2
2
5
2
Total Current Assets
14
34
38
37
31
47
55
58
42
34
PP&E Net
7
9
10
10
10
11
20
20
20
23
PP&E Gross
7
9
10
10
10
11
20
20
20
23
Accumulated Depreciation
11
12
13
13
14
15
18
21
25
27
Intangible Assets
1
2
2
2
2
1
1
1
2
2
Goodwill
2
3
3
3
3
3
3
3
3
3
Long-Term Investments
3
3
4
5
5
6
6
6
5
5
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Other Assets
2
3
3
3
3
3
3
3
3
3
Total Assets
28
N/A
51
+79%
57
+12%
57
+1%
51
-11%
68
+34%
86
+26%
88
+2%
73
-17%
67
-8%
Liabilities
Accounts Payable
2
3
3
3
3
4
2
3
4
21
Accrued Liabilities
4
4
8
10
10
11
13
14
11
12
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
1
1
2
2
2
2
Other Current Liabilities
0
0
1
1
0
1
1
0
0
0
Total Current Liabilities
6
7
13
14
15
17
18
18
18
19
Long-Term Debt
0
1
3
3
2
2
10
9
8
34
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Other Liabilities
7
7
10
10
11
12
14
11
8
11
Total Liabilities
13
N/A
16
+22%
26
+62%
27
+3%
28
+3%
31
+11%
42
+37%
40
-7%
35
-11%
65
+84%
Equity
Common Stock
0
1
1
1
1
1
1
1
1
1
Retained Earnings
54
59
73
73
80
76
70
65
76
118
Additional Paid In Capital
68
91
102
102
102
113
113
113
113
119
Unrealized Security Profit/Loss
1
1
1
1
1
1
1
1
1
2
Other Equity
0
0
1
1
1
1
1
1
1
1
Total Equity
15
N/A
34
+129%
30
-12%
30
-1%
23
-23%
38
+63%
44
+17%
49
+11%
38
-22%
2
-95%
Total Liabilities & Equity
28
N/A
51
+79%
57
+12%
57
+1%
51
-11%
68
+34%
86
+26%
88
+2%
73
-17%
67
-8%
Shares Outstanding
Common Shares Outstanding
410
546
589
594
596
636
637
1 416
1 717
1 717

See Also

Discover More